Tus kws kho mob
2018 December Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 03, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2861 - 2870 ntawm 3669
Tus kws kho mob
QP97-18 Withdraw Feature Available for Availity Authorizations
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP53-18 Medical Drug Policy Criteria Expanded for Stelara and Simponi Aria
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 27, 2018
Tus kws kho mob
QP23-18 Pharmacy Benefit Exclusion for Crysvita
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2018
Tus kws kho mob
QP36-18 Pre-Admission Notification Update Effective May 21, 2018
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 18, 2018
Tus kws kho mob
QP14-18 Pharmacy Benefit Exclusion for Fasenra
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 19, 2018
Tus kws kho mob
QP79-18 Addition of Drug to the Hereditary Angioedema Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP77-18 Pharmacy Benefit Exclusion for Onpattro (patisiran) Lipid Complex Intravenous (IV) Injection
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 11, 2018
Tus kws kho mob
QP57-18 New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary Angioedema
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 19, 2018
Tus kws kho mob
QP39-18 Provider Cost Data Update
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2018